Cabaletta Bio Stock Discussion

$Cabaletta Bio (CABA.US)$ poor stock … not growing at all

$Cabaletta Bio (CABA.US)$ what happened to it … no improvement at all

$Cabaletta Bio (CABA.US)$
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024
Cabaletta Bio (Nasdaq: CABA) announced two presentations at the upcoming American College of Rheumatology (ACR) Convergence 2024, featuring new and updated clinical data on CABA-201, their 4-1BB-containing fully human CD19-CAR T cell investigational therapy. The presentations will cover:
1. An oral presentation on the safety and efficacy of C...

Testing the bottom of the GAP at 4.82. Here are the levels to keep on watch.
Larger Image: tradingview.com...
$Cabaletta Bio (CABA.US)$  

$Annovis Bio (ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...

Ough! Cup with broken handle, it looks great until today.
$Cabaletta Bio (CABA.US)$

$Cabaletta Bio (CABA.US)$ isn't it great that we now punish good stocks with good news... they need to fix this crap, all these meidcal companies rely a lot on share prices...

$Cabaletta Bio (CABA.US)$
this is one of the most beautiful, perfect looking cup + handle graphs Ive ever seen